The following represents disclosure information provided by authors of this abstract. The Genitourinary Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Identification of prostate cancer-expressed microRNAs associated with clinical recurrence (cR) and prostate cancer-specific survival (PCSS) following radical prostatectomy (RP).
Eric A. Klein
Consultant or Advisory Role - Genomic Health
Research Funding - Genomic Health
Mike Kiefer
Employment or Leadership Position - Genomic Health
Stock Ownership - Genomic Health
Michael Crager
Employment or Leadership Position - Genomic Health
Stock Ownership - Genomic Health
Cristina Magi-Galluzzi
Research Funding - Genomic Health
Sara Moscovita Falzarano
Research Funding - Genomic Health
Robert J. Pelham
Employment or Leadership Position - Genomic Health
Stock Ownership - Genomic Health
Carl Millward
Employment or Leadership Position - Genomic Health
Stock Ownership - Genomic Health
Diana B. Cherbavaz
Employment or Leadership Position - Genomic Health
Stock Ownership - Genomic Health
Joffre Baker
Employment or Leadership Position - Genomic Health
Stock Ownership - Genomic Health
Steven Shak
Employment or Leadership Position - Genomic Health
Stock Ownership - Genomic Health
Mark Lee
Employment or Leadership Position - Genomic Health
Stock Ownership - Genomic Health